Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker LSF
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Gregory B. Graves Director | LSF Laird Superfood, Inc. | Buy | 15,000 | $3.45 | $51.8K Buy | Form 4 ↗ |
| Jun 5, 2026 | Grant J. LaMontagne Director | LSF Laird Superfood, Inc. | Buy | 6,910 | $3.30 | $22.8K Buy | Form 4 ↗ |
| Jun 4, 2026 | Grant J. LaMontagne Director | LSF Laird Superfood, Inc. | Buy | 8,826 | $3.23 | $28.5K Buy | Form 4 ↗ |
| Jun 3, 2026 | Grant J. LaMontagne Director | LSF Laird Superfood, Inc. | Buy | 17,054 | $3.30 | $56.3K Buy | Form 4 ↗ |
| Jun 2, 2026 | Grant J. LaMontagne Director | LSF Laird Superfood, Inc. | Buy | 27,160 | $3.30 | $89.6K Buy | Form 4 ↗ |
| May 29, 2026 | Grant J. LaMontagne Director | LSF Laird Superfood, Inc. | Buy | 6,610 | $3.30 | $21.8K Buy | Form 4 ↗ |
| May 28, 2026 | Grant J. LaMontagne Director | LSF Laird Superfood, Inc. | Buy | 624 | $3.30 | $2,059 Buy | Form 4 ↗ |
| May 22, 2026 | Grant J. LaMontagne Director | LSF Laird Superfood, Inc. | Buy | 615 | $3.30 | $2,030 Buy | Form 4 ↗ |
| May 21, 2026 | Grant J. LaMontagne Director | LSF Laird Superfood, Inc. | Buy | 87 | $3.30 | $287 Buy | Form 4 ↗ |
| May 20, 2026 | Grant J. LaMontagne Director | LSF Laird Superfood, Inc. | Buy | 22,850 | $3.28 | $74.9K Buy | Form 4 ↗ |
| May 23, 2025 | Gregory B. Graves Director | LSF Laird Superfood, Inc. | Sale | 2,127 | $7.03 | $15.0K Sale | Form 4 ↗ |
| Mar 5, 2025 | Anna Hamill Chief Financial Officer | LSF Laird Superfood, Inc. | Buy | 2,500 | $5.50 | $13.8K Buy | Form 4 ↗ |
| Mar 5, 2025 | Anna Hamill Chief Financial Officer | LSF Laird Superfood, Inc. | Buy | 183 | $5.40 | $988 Buy | Form 4 ↗ |
| Mar 4, 2025 | Jason D. Vieth Chief Executive Officer, Director | LSF Laird Superfood, Inc. | Buy | 5,000 | $5.50 | $27.5K Buy | Form 4 ↗ |
| Mar 4, 2025 | Jason D. Vieth Chief Executive Officer, Director | LSF Laird Superfood, Inc. | Buy | 5,000 | $5.23 | $26.1K Buy | Form 4 ↗ |
| Mar 4, 2025 | Anna Hamill Chief Financial Officer | LSF Laird Superfood, Inc. | Buy | 834 | $5.71 | $4,762 Buy | Form 4 ↗ |
| Mar 4, 2025 | Anna Hamill Chief Financial Officer | LSF Laird Superfood, Inc. | Buy | 87 | $5.70 | $496 Buy | Form 4 ↗ |
17 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:35 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances